NEUE REGULATIONSELEMENTE

European patent · EP2310501 · In force

Register entry

Publication number
EP2310501
Application number
EP09800055
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 22, 2009
Published
Apr 20, 2011
Granted
Jul 3, 2013
Protection ends at the latest
Jul 21, 2029
Next annual fee due
Jul 31, 2027
IPC classes
C12N 15/09 (2006.01)
C12N 15/11 (2006.01)
C12N 15/67 (2006.01)
Priority
EP 08161029 23.07.2008
PCT application
PCT/EP2009/059399 22.07.2009
PCT publication
WO2010/010107 28.01.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Jul 3, 2013

    Granted

    Published in Swissreg on 03.07.2013

Parties

Holder

Boehringer Ingelheim Pharma GmbH & Co. KG

Binger Straße 173, 55216 Ingelheim am Rhein, DE

Inventor

ENENKEL, Barbara

55216 Ingelheim Am Rhein, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.